MedPath

Comparing the effectiveness of electric stimulation therapy and pilocarpine mouthwash on salivary flow in patients with dry mouth: clinical trial

Phase 3
Conditions
Health Condition 1: K117- Disturbances of salivary secretion
Registration Number
CTRI/2024/04/065408
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants who meet the eligibility requirements for the study are those who have completed radiation therapy with or without chemotherapy or surgery between three months and two years prior to study entry, and who report symptoms of oral dryness and decreased salivary flow (= 0.2 mL/min).

All participants who are willing to give written informed consent.

Exclusion Criteria

Participants with a history of known salivary gland pathologies, such as rheumatoid arthritis and Sjogrens syndrome.

Those who are taking drugs like pilocarpine, cevimeline, inhalatory glucocorticoids, opioids, benzodiazepines, diuretics, or who have undergone surgery involving the salivary glands.

Participants with hearing aids, cochlear implants, pacemakers or defibrillators will be excluded from the study.

Participants who have peptic ulcers or uncontrolled asthma will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath